This short report describes a questionnaire study undertaken in two London teaching hospitals, addressing the true pharmacokinetic implications of aspirin use. It suggests that the real costs of aspirin treatment should include the cost of the therapies used for treatment of associated dyspepsia.
Costs of aspirin should include treatment costs for dyspepsia
May 2007Br J Cardiol 2007;14:169-70 Leave a commentClick any image to enlarge